Detalles de la búsqueda
1.
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial.
Br J Cancer
; 127(4): 695-703, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35610366
2.
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
Cancer Immunol Immunother
; 69(8): 1549-1564, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303794
3.
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
BMC Cancer
; 19(1): 535, 2019 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31159747
4.
Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients.
Cancer Genomics Proteomics
; 19(1): 60-78, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34949660
5.
Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center.
Cancer Genet
; 220: 1-12, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29310832
6.
Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
PLoS One
; 13(7): e0200302, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30063723
Resultados
1 -
6
de 6
1
Próxima >
>>